Obagi’s public tretinoin record adds a standard prescription preparation to a directory that also contains personalized cream services and a lotion comparator. Its value begins with concrete identifiers: the molecule, strength options and dosage forms. A brand name alone would leave too much room to confuse different products.
The official manufacturer page and AAD references were checked on October 14, 2026. We did not obtain a prescription, contact a pharmacy for a personal quote or use the medicine. The review explains the limits of the manufacturer record without selecting a strength or claiming a treatment experience.
- Access
- Prescription
- Cream
- 0.025%, 0.05% or 0.1% tretinoin
- Gel
- 0.05% tretinoin
- Published context
- Acne vulgaris
- Personal quote
- Not established
The public options are cream and gel
Obagi lists tretinoin cream at 0.025%, 0.05% and 0.1%, plus a 0.05% gel. Its stated clinical context is acne vulgaris. The option names are useful identifiers, but the manufacturer overview is not a record of which preparation any individual has been prescribed. [1]
The supplied label should retain the exact strength and vehicle together. Our vehicle notebook explains why dosage-form wording deserves attention. Two preparations sharing a molecule or percentage should not be assumed to have identical supporting ingredients, delivery characteristics or personal tolerability.
Other Obagi products do not inherit this prescription identity
The wider catalog includes retail retinol, pigment products and salicylic-acid skincare. Those are separate formulations with separate ingredient records. A Clear Fx serum, Clear Rx product or Pore Therapy liquid should not be treated as another name for the tretinoin cream simply because the logo matches.
The same principle applies to a custom blend from another provider. An added active, different base or different prescribing arrangement can change the relevant questions. Our standard-versus-custom guide keeps those distinctions visible rather than merging all tretinoin-containing offers into one product.
Fragrance-free is one characteristic of the vehicle
The manufacturer describes these formulations as fragrance-free. That information may be useful when reading a proposed medicine’s supporting ingredients. It does not establish that irritation is impossible, and it does not replace the current warnings and ingredient information supplied with a prescription. [1]
We have no direct observation of how either vehicle spreads, dries or feels on skin. AAD’s ingredient-family guidance provides background on retinoids, but it cannot predict an individual experience with this preparation. Questions about discomfort should use the exact medicine name and label, rather than a broad brand description. [2]
Keep the acne context attached to the record
The manufacturer’s acne statement is not evidence that every cosmetic goal is an approved use of this preparation. Wrinkle, pigmentation and texture discussions need their own indication and evidence context. A review should not silently broaden the described purpose because a reader arrived through an anti-aging search. [1]
Nor can the Crystal Retinal comparison establish prescription equivalence through a related ingredient name. Clinical decisions belong to the responsible professional. This page supplies no application frequency, treatment duration, combination protocol or instruction to switch from an existing medicine.
The manufacturer overview does not fix a personal cost
A pharmacy price, insurance contribution and current local supply were not established by this review. An authorized-retailer or product-information link is not a completed quote. The consultation, actual medicine, dispensing arrangement and any repeat-order obligations need to be identified before comparing total costs.
The price comparison guide separates a visible headline amount from the actual commitment. Direct-store returns for ordinary cosmetics should not automatically be assigned to a dispensed prescription. We have not confirmed a particular seller’s policy for this medicine or completed a purchase to test it.
The clinical conversation still requires individual information
AAD’s acne-care advice offers general context for gentle skincare and avoiding unnecessary irritation. It does not establish that a visitor to this publication has been assessed or that a manufacturer page has addressed their medical history. Reading the page is not equivalent to a clinical consultation. [3]
Pregnancy, breastfeeding, concurrent medicines and persistent symptoms are examples of information that can change the professional discussion. Bring the exact proposed preparation to that conversation. The questions notebook is an organizational aid, not a substitute for a prescriber’s assessment or the medicine’s supplied instructions.
A precise record is the appropriate outcome here
The public source establishes a named tretinoin range with identified strengths, vehicles and an acne context. It leaves the individual prescription, pharmacy transaction and observed response outside this review. Those limits are part of the conclusion, rather than details to fill with assumptions about the brand.
CoreAge Rx receives disclosed commercial placement in this publication. Its prominence does not establish superiority over Obagi or make a compounded formula interchangeable with a standard preparation. The directory is useful when each entry retains its own identity and supporting evidence, without inventing a common clinical ranking.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Each source has its own last-checked date below.
- Prescription Vitamin A Tretinoin | Obagi MedicalOfficial product or purchase record; claims and transaction performance not independently tested · Checked October 14, 2026
- American Academy of Dermatology — Retinoid or retinol?Dermatology guidance on retinoids, irritation and pregnancy · Checked October 14, 2026
- Acne: Tips for managingIndependent clinical or regulatory context · Checked October 14, 2026